Eterna Therapeutics
ERNA
#11171
Rank
S$2.96 M
Marketcap
S$1.75
Share price
-16.56%
Change (1 day)
-0.49%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -S$21.27 Million

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$18.2 Million, an increase over its 2024 earnings that were of -S$48.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$21.27 Million16.91%
2025 -S$18.2 Million-62.78%
2024 -S$48.88 Million84.63%
2023 -S$26.48 Million-16.24%
2022 -S$31.61 Million-80.08%
2021 -S$0.16 Billion1596.7%
2020 -S$9.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
S$10.04 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-S$0.25 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
S$20.61 M-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-S$24.56 Million 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-S$4.99 Million-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
S$1.57 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
S$0.32 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA